✦ LIBER ✦

The Patient’s Dilemma: Prostate Cancer Treatment Choices

✍ Scribed by PATEL, H.R.H.; MIRSADRAEE, S.; EMBERTON, M.

Book ID: 125475675
Publisher: Lippincott Williams and Wilkins
Year: 2003
Tongue: English
Weight: 87 KB
Volume: 169
Category: Article
ISSN: 0022-5347
DOI: 10.1097/01.ju.0000052056.27609.8a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of patient preferences and tr

Predictors of patient preferences and treatment choices for localized prostate cancer

✍ Benjamin D. Sommers; Clair J. Beard; Anthony V. D'Amico; Irving Kaplan; Jerome P 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Patients' choice of treatment in stage D

Patients' choice of treatment in stage D prostate cancer

✍ Barrie R. Cassileth; Edward James Seidmon; Mark S. Soloway; Howard I. Hait; Nich 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 560 KB

Prostate Cancer from Diagnosis to Treatm

Prostate Cancer from Diagnosis to Treatment: The Patient's View

✍ Louis Denis 📂 Article 📅 2009 🏛 Dougmar Publishing Group, Inc. 🌐 English ⚖ 70 KB

Prostate Cancer - The Patient's View

✍ Werner Pokstefl 📂 Article 📅 2009 🏛 Dougmar Publishing Group, Inc. 🌐 English ⚖ 72 KB

Treatment of breast cancer: the patient'

Treatment of breast cancer: the patient's choice

✍ Spittle, M.F. 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Treatment ‘mismatch’ in early prostate c

Treatment ‘mismatch’ in early prostate cancer : Do treatment choices take patient quality of life into account?

✍ Ronald C. Chen; Jack A. Clark; Judith Manola; James A. Talcott 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Abstract ## BACKGROUND. Pretreatment urinary, bowel, and sexual dysfunction may increase the toxicity of prostate cancer treatments or preclude potential benefits. Using patient‐reported baseline dysfunction from a prospective cohort study, we determined the proportion of patients receiving rel